Pacific Biosciences of California PACB Business Segments — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's business segments — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's business segments — total revenue?
- Pacific Biosciences of California (PACB) reported business segments — total revenue of $37.18M in Q1 2026.
- How has Pacific Biosciences of California's business segments — total revenue changed year-over-year?
- Pacific Biosciences of California's business segments — total revenue increased by 0.1% year-over-year, from $37.15M to $37.18M.
- What is the long-term trend for Pacific Biosciences of California's business segments — total revenue?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's business segments — total revenue has grown at a 7.6% compound annual growth rate (CAGR), from $128.3M to $160.01M.
- What does business segments — total revenue mean?
- This represents the total gross income generated by the company's primary business segment from the sale of sequencing platforms, consumables, and related services. It serves as the primary indicator of market demand and the successful commercial adoption of the company's genetic analysis technology.